Ditchcarbon
  • Contact
  1. Organizations
  2. Haw Par
Public Profile
Pharmaceutical Preparation Manufacturing
SG
updated 15 days ago

Haw Par Sustainability Profile

Company website

Haw Par Corporation Limited, commonly known as Haw Par, is a prominent player in the healthcare and leisure industries, headquartered in Singapore (SG). Founded in 1940, the company has established itself as a leader in the development and distribution of healthcare products, particularly its renowned Tiger Balm range, which is celebrated for its unique formulation and effectiveness in pain relief. With a strong presence in Asia and expanding operations globally, Haw Par has achieved significant milestones, including the diversification of its product portfolio to include leisure and entertainment ventures. The company’s commitment to quality and innovation has solidified its market position, making it a trusted name in both the healthcare sector and the leisure industry. Haw Par continues to thrive, driven by its dedication to enhancing the well-being of consumers worldwide.

DitchCarbon Score

How does Haw Par's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Haw Par's score of 25 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.

43%

Let us know if this data was useful to you

Haw Par's reported carbon emissions

In 2023, Haw Par Corporation Limited reported Scope 2 carbon emissions of approximately 1,654,700 kg CO2e. This figure represents a notable increase from the previous year's emissions of about 1,347,300 kg CO2e in 2022, and 1,306,200 kg CO2e in 2021. The company has not disclosed any Scope 1 or Scope 3 emissions data. Despite the increase in emissions, Haw Par has not set specific reduction targets or initiatives as part of its climate commitments. The absence of documented reduction targets suggests that the company may be in the early stages of developing a comprehensive climate strategy. Haw Par's emissions data is not cascaded from a parent organization, indicating that the reported figures are solely from its own operations. The company is headquartered in Singapore (SG) and operates within a global context, reflecting its commitment to transparency in environmental reporting.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2020202120222023
Scope 1
-
-
-
-
Scope 2
1,168,600
0,000,000
0,000,000
0,000,000
Scope 3
-
-
-
-

How Carbon Intensive is Haw Par's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Haw Par's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Haw Par's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Haw Par is in SG, which has a very low grid carbon intensity relative to other regions.

Haw Par's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Haw Par has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Haw Par's Emissions with Industry Peers

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated about 12 hours ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy